Agro-Bio took the opportunity of the last EBF congress to communicate about one of its collaborations with Sanofi research team.
Lionel Cambrils - Manager Sales - with a Sanofi researcher spoke about our works. They presented a poster during the poster session on last Friday morning (11/23/2018) of EBF congress in Barcelona.
For this phase-I clinical project, Agro-Bio offered its expertise on anti-idiotypic antibody development. The aim was to develop antibodies (monoclonal and polyclonal) to set up a sensitive (pg/mL) pharmacocinetic test for a potential therapeutic moleclule.
To learn more about the research. Follow us on LinkedIn.